Product Information

ALYACEN 1-35 28 TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1936 per EA under NDC 68462039429. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Jan 19, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ALYACEN 1-35 28 TABLET

norethindrone and ethinyl estradiol
$0.1936per EA

NDC

68462039429

Classification

Generic

Dosage Form

KIT

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA091634

FDA Approved

1/19/2012

TE Code

AB

On Market Since

1/19/2012

Price Statistics

The NADAC for ALYACEN 1-35 28 TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 63.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1936 per EA
All-time high$0.5877 (Feb 12, 2014)
All-time low$0.1935 (May 22, 2024)
52-week high$0.2225
52-week low$0.1936
Median price$0.3936
Average price$0.3740
Largest weekly change+39.2% (Jun 19, 2024)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-4.5%

3M

-7.5%

6M

-2.3%

1Y

-11.6%

3Y

-29.3%

5Y

-34.6%

All

-63.8%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ALYACEN 1-35 28 TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ALYACEN 1-35 28 TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1936 per EA (NDC 68462039429), effective Nov 11, 2026.

How has the price of ALYACEN 1-35 28 TABLET changed over time?

Over the history we have for it, the NADAC for ALYACEN 1-35 28 TABLET has declined 63.8%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ALYACEN 1-35 28 TABLET?

Since Nov 28, 2013, the NADAC for ALYACEN 1-35 28 TABLET has ranged from a low of $0.1935 (May 22, 2024) to a high of $0.5877 (Feb 12, 2014), with a median of $0.3936 per EA.

Are there cheaper alternatives to ALYACEN 1-35 28 TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ALYACEN 1-35 28 TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ALYACEN 1-35 28 TABLET?

ALYACEN 1-35 28 TABLET (NDC 68462039429) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.